Skip to content

Psychedelic Neuroplasticity Protocol

Core Argument

The cannabinoid and serotonergic systems are neuroplasticity levers. Targeted activation of these systems supports: 1. Micro-trauma clearance (daily emotional/physical residue) 2. Enhanced neural remodeling (edge formation/dissolution) 3. Dimensional flexibility (hypervisor switching fluidity)

Two Systems

1. Cannabinoid System (THC/CBD)

  • Receptor: CB1 (brain), CB2 (immune/peripheral)
  • Effect: Modulates synaptic transmission, reduces neuroinflammation
  • Framework role: Reduces friction in hypervisor switching — dimensions can compete more fluidly when the cannabinoid system is supporting synaptic flexibility
  • Micro-trauma clearance: Daily emotional residue (interpersonal friction, physical bumps, stress responses) creates micro-damage to the graph edges. Cannabinoid activation supports the clearance of this residue.

2. Serotonergic Psychedelics (Psilocybin, LSD)

  • Receptor: 5-HT2A
  • Active compound: Psilocybin (mushrooms), LSD (both act on same receptor system)
  • Effect: Massive increase in neural plasticity — the brain becomes temporarily more malleable
  • Framework role: The ultimate edge reorganization tool. Under psychedelic influence, the graph can dissolve unhealthy edges (trauma-formed rigid connections) and form new edges (novel cross-dimensional connections)
  • Research: Psilocybin shown to produce lasting increases in openness, reduce treatment-resistant depression, promote neurogenesis

The Maintenance Argument

Just as Chapter 11 (The Chemistry) describes a pharmaceutical maintenance protocol for the biological substrate after age 35, this is the plasticity maintenance protocol:

  • Daily: Cannabinoid support (THC/CBD) for micro-trauma clearance and synaptic flexibility
  • Periodic: Psilocybin/psychedelic sessions for deep graph reorganization and edge remodeling

Niko: "We should be doing that all the time too, just to clean out all the micro-traumas that we collect every day just by being alive, bumping into people emotionally and physically."

Connection to Trauma Recovery (Book 4: Zap)

The percolation threshold (p_c ≈ 7/12) can be reached faster when neuroplasticity is pharmacologically supported: - Psychedelics lower the energy barrier for forming new cross-dimensional edges - Cannabinoids maintain synaptic flexibility so new edges persist - Combined with the pharmaceutical stack (Vyvanse, Wellbutrin, DXM, Citicoline, Creatine, Metformin), this creates a comprehensive substrate optimization protocol

Age Gate

Same principle as Chapter 11: the brain before ~35 has sufficient natural plasticity. After 35, pharmacological support becomes increasingly important as natural neuroplasticity declines.

Source: @B_Niko, session v7, 2026-03-10